跳至主要内容
临床试验/NCT06267976
NCT06267976已完成不适用

Validation of the ProSomnus® RPMO2 Pulse Oximeter Device

ProSomnus Sleep Technologies1 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2024年6月10日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
12
试验地点
1
主要终点
SpO2 accuracy

研究概览

简要总结

The purpose of the study is to:

  1. Evaluate the SpO2 accuracy of the oximeter component of the ProSomnus RPMO2 Device during non-motion conditions over the range of 70-100% SaO2 by comparison to SaO2 values determined by arterial blood sample specimen analyzed by a CO-oximeter.
  2. Evaluate the pulse rate performance simultaneously collected over the SpO2 range.

详细描述

Testing will be performed with participants semi-recumbent, under non-motion conditions. SpO2 accuracy of the test device will be determined by a controlled desaturation study with measurements taken over the full range of SaO2 values for which accuracy is to be claimed +3% of the lower value and -3% of the upper value. Participants will be desaturated to achieve six plateaus between 100-70% SaO2.

Arterial blood draws within the hypoxic plateaus will be performed, with draws occurring no less than 30 seconds after reaching a plateau and no less than 20 seconds apart. Five blood draws will be taken at each plateau. Plateaus will be determined using the reference transmittance pulse oximeter and are defined as a change in SpO2 on the reference pulse oximeter of no more than 1% over a duration of 20 seconds. Sampling will not continue if the blood oxygen saturation destabilizes between blood draws.

Time in low O2 saturation decades (i.e., 70-80% and 80-90%) will be limited to the minimum amount of time required to obtain test data and will not exceed 10 minutes. The saturation level at each plateau and the number of plateaus may vary among participants. Arterial pressure, ECG, heart rate, EtCO2, respiratory rate, and FiO2 will be monitored during testing. Extra samples may be collected at the discretion of the PI. The controlled desaturation protocol is expected to take approximately 30 to 60 minutes.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female, aged ≥ 18 and < 50 years.
  • In good health with no evidence of medical problems.
  • Ability to provide informed consent and willingness to comply with the study procedures.
  • Ability to undergo controlled hypoxemia to the levels outlined in the desaturation profile.
  • Adequate dentition for an oral appliance.
  • Ability to breathe through the nose comfortably.

排除标准

  • Obesity (BMI > 40 kg/m2).
  • Known history of heart, lung, kidney, or liver disease.
  • Diagnosis of asthma or sleep apnea.
  • Diagnosis of diabetes.
  • Presence of a clotting disorder.
  • Presence of hemoglobinopathy or history of anemia that, in the opinion of the PI, makes the individual unsuitable for participation.
  • Current smoker.
  • History of fainting or vasovagal response.
  • History of sensitivity to local anesthesia.
  • Unacceptable collateral circulation based on exam (Allen's test).
  • Pregnancy or lactation.
  • Resting heart rate > 120 bpm.
  • Systolic BP > 150, diastolic BP >
  • Carboxyhemoglobin level > 3%.
  • Presence of any other condition that, in the opinion of the PI, makes the individual unsuitable for participation.

结局指标

主要结局

SpO2 accuracy

时间窗: 2 hours

Root-mean-square (Rms) ± 3.5 \[% SpO2\] over the range of 70 to 100% SaO2

Pulse rate accuracy

时间窗: 2 hours

Rms within ± 3 \[1/min\] over the claimed range

次要结局

未报告次要终点

研究者

发起方
ProSomnus Sleep Technologies
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验